The DOI matches its Crossref record; 181 of the 181 references it cites were found in a registry or an index.
Psychosis in Alzheimer disease—mechanisms, genetics and therapeutic opportunities
Open accessAbstract
Psychosis is a common and distressing symptom in people with Alzheimer disease, and few safe and effective treatments are available. However, new approaches to symptom assessment and treatment are beginning to drive the field forward. New nosological perspectives have been provided by incorporating the emergence of psychotic symptoms in older adults - even in advance of dementia - into epidemiological and neurobiological frameworks as well as into diagnostic and research criteria such as the International Psychogeriatric Association criteria for psychosis in neurocognitive disorders, the Alzheimer's Association International Society to Advance Alzheimer's Research and Treatment (ISTAART) research criteria for psychosis in neurodegenerative disease, and the ISTAART criteria for mild behavioural impairment. Here, we highlight the latest findings in genomics, neuroimaging and neurobiology that are informing approaches to drug discovery and repurposing. Current pharmacological and non-pharmacological treatment options are discussed, with a focus on safety and precision medicine. We also explore trial data for pimavanserin, a novel agent that shows promise for the treatment of psychosis in people with dementia, and discuss existing agents that might be useful but need further exploration such as escitalopram, lithium, cholinesterase inhibitors and vitamin D. Although the assessment and management of psychosis in people with dementia remain challenging, new opportunities are providing direction and hope to the field.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Methylphenidate, a dopamine transporter blocker that increases dopamine levels, seems to show mild improvement in apathy, the most prevalent disorder among the neuropsychiatric symptoms of AD [73].”
From Current therapeutics for Alzheimer’s disease and clinical trials (2024) · cites this paper as [73]
Experimental — accuracy not yet measuredIn the citing paper
“the most prevalent disorder among the neuropsychiatric symptoms of AD [73]”
From Current therapeutics for Alzheimer’s disease and clinical trials (2024) · cites this paper as [73]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hirono, N., Mori, E., Ikejiri, Y., Imamura, T., Shimomura, T., Hashimoto, M., Yamashita, H., & Ikeda, M. (1997) · PubMed · Cited by 21,012
Schneider, L. S., Dagerman, K. S., & Insel, P. (2005) · JAMA · doi:10.1001/jama.294.15.1934 · Cited by 1,671
Neuropsychiatric symptoms in Alzheimer's disease
Lyketsos, C. G., Carrillo, M. C., Ryan, J. M., Khachaturian, A. S., Trzepacz, P., Amatniek, J., Cedarbaum, J., Brashear, R., & Miller, D. S. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.05.2410 · Cited by 1,139
Self-citationCummings, J. L., Isaacson, S., Mills, R., Williams, H., Chi‐Burris, K., Corbett, A., Dhall, R., & Ballard, C. G. (2013) · The Lancet · doi:10.1016/s0140-6736(13)62106-6 · Cited by 954
Self-citationSchneider, L. S., Dagerman, K., & Insel, P. S. (2006) · The American Journal of Geriatric Psychiatry · doi:10.1097/01.jgp.0000200589.01396.6d · Cited by 903
Ismail, Z., Smith, E. E., Geda, Y., Sultzer, D., Brodaty, H., Smith, G., Agüera‐Ortiz, L., Sweet, R., Miller, D., Lyketsos, C. G., et al. (2016) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2015.05.017 · Cited by 818
Self-citationPoint and 5‐year period prevalence of neuropsychiatric symptoms in dementia: the Cache County Study
Steinberg, M., Shao, H., Zandi, P., Lyketsos, C. G., Welsh‐Bohmer, K. A., Norton, M. C., Breitner, J. C. S., Steffens, D. C., & Tschanz, J. T. (2008) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.1858 · Cited by 780
Self-citationMaust, D. T., Kim, H. M., Seyfried, L. S., Chiang, C., Kavanagh, J., Schneider, L. S., & Kales, H. C. (2015) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2014.3018 · Cited by 617
Self-citationKaufer, D., Cummings, J. L., Christine, D., Bray, T., Castellon, S., Masterman, D. L., MacMillan, A., Ketchel, P., & DeKosky, S. T. (1998) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1998.tb02542.x · Cited by 607
Kales, H. C., Gitlin, L. N., Lyketsos, C. G., & Dementia, T. D. E. P. O. T. A. A. M. O. T. N. S. O. (2014) · Journal of the American Geriatrics Society · doi:10.1111/jgs.12730 · Cited by 575
Self-citation
Research works printed but not linked: 2
- Nathan, S., Gill, S. & Ismail, Z. in Alzheimer’s Association International Conference (ALZ, 2020).
- Lussier, F. et al. Mild behavioral impairment is associated with beta-amyloid and tau across the alzheimer’s disease spectrum. J. Cereb. Blood Flow. Metab. 39, 158–159 (2019).
Cited by
Sorted by citations
Items 101–189 of 189
Zhou, D., Tong, H., Wang, L., Liu, S., Xiong, X., Gan, Z., Griffier, R., Hejblum, B. P., Liu, Y., Hong, C., et al. (2026) · Nature Communications · doi:10.1038/s41467-026-71152-1 · Cited by 15
Delusional Severity Is Associated with Abnormal Texture in FLAIR MRI
Khoury, M. A., Bahsoun, M., Fadhel, A., Shunbuli, S., Venkatesh, S., Ghazvanchahi, A., Mitha, S., Chan, K., Fornazzari, L., Churchill, N. W., et al. (2022) · Brain Sciences · doi:10.3390/brainsci12050600 · Cited by 4
Self-citationKwak, S., Kim, H., Kim, K. Y., Oh, D. Y., Lee, D., Nam, G., & Lee, J. (2024) · BMC Neurology · doi:10.1186/s12883-024-03568-5 · Cited by 5
Good, M. A., & Bannerman, D. M. (2024) · Current topics in behavioral neurosciences · doi:10.1007/7854_2024_565 · Cited by 4
Tang, C., Yang, J., Lei, X., Zhang, M., Chen, Y., Peng, X., & He, D. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70605 · Cited by 5
Pineal volume reduction as the neural correlate of very late-onset schizophrenia-like psychosis
Matsuoka, T., Imai, A., & Narumoto, J. (2022) · Asian Journal of Psychiatry · doi:10.1016/j.ajp.2022.103251 · Cited by 4
Daganatos nőbetegek termékenységének megőrzése.
Vesztergom, D., Nánássy, L., Polgár, C., Krádi, A., Rosta, V., Varga, S., & Novàk, Z. (2023) · Orvosi Hetilap · doi:10.1556/650.2023.32823 · Cited by 4
Namasivayam, A. A., Fischer, C. E., Abler, V., Creese, B., Gastiazoro, M. P., Hermida, A. P., Ikeda, M., Ismail, Z., Jeste, D. V., McDermid, J., et al. (2025) · International Psychogeriatrics · doi:10.1016/j.inpsyc.2025.100133 · Cited by 3
Self-citationPetrov, W., Ślebioda, D., Kozińska, R. B., Kukla, K., Petrov, P., Sroka, M., Tesyna, J., Puźniak, G., Kudliński, M., Rejda, T., et al. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27135733 · Cited by 4
Ballard, C. G., Mills, K., Soto, M., Cummings, J. L., Mintzer, J. E., Grossberg, G. T., Ikeda, M., Pathak, S. S., Fischer, C. E., & McDermid, J. (2025) · International Psychogeriatrics · doi:10.1016/j.inpsyc.2025.100118 · Cited by 3
Self-citationZou, Q., Shang, J., Liu, J.-X., & Gao, R. (2024) · IEEE Journal of Biomedical and Health Informatics · doi:10.1109/jbhi.2024.3442468 · Cited by 4
Miranda, O., Jiang, C., Qi, X., Kofler, J., Sweet, R. A., & Wang, L. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26041617 · Cited by 3
Self-citationFloros, G. D., Mylona, I., & Kandarakis, S. (2025) · Diseases · doi:10.3390/diseases13070224 · Cited by 2
Novel predictors of Alzheimer's disease in Down syndrome identified using machine learning
Rubenstein, E., Tewolde, S., Michals, A. L., Fortea, J., Jimenez, M. P., Skotko, B. G., Tripodis, Y., Weuve, J., & Rosellini, A. J. (2025) · Journal of Alzheimer s Disease · doi:10.1177/13872877251385423 · Cited by 2
Antipsychotics in Alzheimer’s Disease: Current Status and Therapeutic Alternatives
Maziero, M. P., Rocha, N. P., & Teixeira, A. L. (2023) · Current Alzheimer Research · doi:10.2174/0115672050287534240215052417 · Cited by 2
Scarfo, S., Moshfeghi, Y., & McGeown, W. J. (2024) · Current Alzheimer Research · doi:10.2174/0115672050309014240705113444 · Cited by 2
Alexandre-Silva, V., Soares‐Silva, B., Pereira, G. C., Custódio‐Silva, A. C., Carvalhinho-Lopes, P. S., Taliano, L. O., Lambertucci, R. H., Duarte, M. C., Araújo, A. A. D. S., Quintans‐Júnior, L. J., et al. (2024) · Metabolic Brain Disease · doi:10.1007/s11011-024-01484-8 · Cited by 2
Genetic and neurobiological aspects of psychosis in major neurocognitive disorder
Abarca, M., Pizarro, H., Bustamante, M. L., Rohde, G., & Marcelo Arancibia, M. (2025) · Medwave · doi:10.5867/medwave.2025.01.2994 · Cited by 1
Perini, G., Ramusino, M. C., Vergani, M., Gatti, A., Imbimbo, C., Leone, S., Ballante, E., Allegri, N., D’Antonio, F., Zuffi, M., et al. (2025) · Journal of Alzheimer s Disease · doi:10.1177/13872877251344631 · Cited by 2
Neural correlates of delusion in Alzheimer's disease and Mild Cognitive ImpairmentPreprint
Kwak, S., Kim, H., Kim, K. Y., Lee, D., Oh, D. Y., Nam, G., & Lee, J. (2022) · Research Square · doi:10.21203/rs.3.rs-2085067/v1 · Cited by 2
Johnson, A. S., Ziaggi, G., Smith, A. C., Houlihan, H. M., Heuer, L. B., Guzmán, D. S., Okafor, A., Huey, E. D., Talmasov, D., Provenzano, F. A., et al. (2024) · medRxiv · doi:10.1101/2024.01.12.24301221 · Cited by 2
Ballard, C., McDermid, J., Mills, K., Sweetnam, A., & Fossey, J. (2024) · medRxiv · doi:10.1101/2024.09.12.24313538 · Cited by 2
Self-citationZhou, J., Han, Z., Xin, M., He, X., Wang, G., Song, J., Luo, G., He, W., Li, X., Chu, Y., et al. (2025) · medRxiv · doi:10.1101/2025.04.29.25326370 · Cited by 2
Cao, S., Guo, R., Fu, Z., Liu, Y., Wu, T., Zhou, Z., Zhang, J., Liu, X., Song, Y., & Ma, J. (2023) · Stem Cell Research · doi:10.1016/j.scr.2023.103052 · Cited by 1
Clinical Pipelines for Alzheimer’s Disease Psychosis and Agitation
Oguma, T., & Jino, K. (2024) · Chemical and Pharmaceutical Bulletin · doi:10.1248/cpb.c23-00416 · Cited by 1
da Silva, R., & Cavalheiro, É. T. G. (2024) · Journal of Electroanalytical Chemistry · doi:10.1016/j.jelechem.2024.118555 · Cited by 1
Kim, S. Y., & Lee, S. J. (2024) · PeerJ · doi:10.7717/peerj.18026 · Cited by 1
Carmel, J., Clerc, D., Couture, V., Reid, I., Filali, A., & Villalpando, J. M. (2024) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0000000000000644 · Cited by 1
Correlation of Alzheimer’s Disease and Other Psychological and Non-Psychological Conditions
Boiko, D. I., Zhyvotovska, L. V., Боднарь, Л. А., Rud, V. O., Vasylyeva, G. Y., & Skrypnikov, A. M. (2024) · Springer eBooks · doi:10.1007/978-981-96-0259-9_5 · Cited by 1
Gómez-Acero, L., Sánchez-Fernández, N., Subirana, P., Ciruela, F., & Aso, E. (2025) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2025.173970 · Cited by 2
Neurobiology of Behavioral and Psychological Symptoms of Dementia
Tampi, R. R., Joshi, P., & Zdanys, K. F. (2025) · Advances in Psychiatry and Behavioral Health · doi:10.1016/j.ypsc.2025.01.002 · Cited by 1
Cheng, Z., Wang, S., Hua, X., Zhang, L., Li, B., Li, H., Bai, Y., Li, Y., Hao, J.-P., Wang, J., et al. (2025) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2025.116818 · Cited by 1
Creese, B., Cummings, J. L., Fischer, C. E., Jeste, D., Ikeda, M., Mills, K., Ismail, Z., & Ballard, C. G. (2025) · International Psychogeriatrics · doi:10.1016/j.inpsyc.2025.100094 · Cited by 2
Self-citationPoszwa, J., Słowikowski, B. K., Owecki, W., Szymanowicz, O., Jagodziński, P. P., Kozubski, W. P., & Dorszewska, J. (2025) · Current Alzheimer Research · doi:10.2174/0115672050390340250716061313 · Cited by 1
Plasma biomarkers in neuropsychiatric syndromes: A narrative review
Ismail, Z., Guan, D. X., Babulal, G. M., Bateman, J. R., Cantillon, M., Creese, B., D’Antonio, F., Fischer, C. E., Gatchel, J. R., Ghahremani, M., et al. (2025) · Journal of Alzheimer s Disease · doi:10.1177/13872877251392185 · Cited by 3
Self-citationZhao, B., Wang, Y., Wang, Y., Ji, C., & Zhang, N. (2026) · International Psychogeriatrics · doi:10.1016/j.inpsyc.2026.100190 · Cited by 1
Rajkumar, G., Uthayakumar, H., Khoury, M. A., Valcic, M., Rashidi‐Ranjbar, N., Churchill, N. W., Fornazzari, L., Luca, V. D., Ismail, Z., Graham, S. J., et al. (2026) · American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2026.02.011 · Cited by 1
Self-citationBoyanova, S., Katsouri, L., Krupic, J., Hair, K., Wang, S., & Wiseman, F. K. (2026) · STAR Protocols · doi:10.1016/j.xpro.2026.104633 · Cited by 1
Zerva, M.-C., Triantafylloudis, C., Paspaliaris, V., Skoulakis, E. M. C., & Papanikolopoulou, K. (2024) · Cells · doi:10.3390/cells13090746 · Cited by 1
Nassan, M. M. (2024) · Harvard Review of Psychiatry · doi:10.1097/hrp.0000000000000399 · Cited by 1
Delusional Severity Is Associated with Abnormal Texture in FLAIR MRI
Khoury, M. A., Bahsoun, M., Fadhel, A., Shunbuli, S., Venkatesh, S., Ghazvanchahi, A., Mitha, S., Chan, K., Fornazzari, L., Churchill, N. W., et al. (2022) · doi:10.32920/21287931 · Cited by 1
Self-citationDefining Dementia Subtypes Through Neuropsychiatric Symptom-Linked Brain Connectivity PatternsPreprint
Zhao, K., Xie, H., Fonzo, G. A., Carlisle, N. B., Osorio, R. S., & Zhang, Y. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.07.02.547427 · Cited by 1
Maffoni, M., & Magnani, A. (2025) · Springer eBooks · doi:10.1007/978-3-031-40858-8_193-1 · Cited by 2
Computational Attitudes to Drug Discovery in Alzheimer's Disease
Maheshwari, S., Singh, A., Verma, A., Akhtar, J., Prajapati, J. B., Singh, S. K., & Prajapati, B. G. (2025) · doi:10.1002/9781394242474.ch11 · Cited by 1
Compensatory Plasticity Defines a Vulnerable Neuronal State in Alzheimer’s Disease with PsychosisPreprint
Victor, M. B., Sun, N., Galani, K., Leary, N., Tanigawa, Y., Scannail, A. N., Ho, L., Prosper, S., Liu, L., Kofler, J., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.04.30.651435 · Cited by 1
Self-citationLeon, T. (2022) · International Psychogeriatrics · doi:10.1017/s1041610222000059 · Cited by 1
Woldemariam, S. R., Tang, A., Oskotsky, T., Yaffe, K. S., & Sirota, M. (2022) · Research Square · doi:10.21203/rs.3.rs-1930345/v1
Delusional Severity Is Associated with Abnormal Texture in FLAIR MRI
Khoury, M. A., Bahsoun, M., Fadhel, A., Shunbuli, S., Venkatesh, S., Ghazvanchahi, A., Mitha, S., Chan, K., Fornazzari, L., Churchill, N. W., et al. (2022) · doi:10.32920/21287931.v1
Self-citationVeeraraghavan, V., & Agarwal, D. (2022) · Geriatric Care · doi:10.4081/gc.2022.10818
Drugs for Alzheimer’s and Other Dementia: Are they Worth Anything?
Belmaker, R. H., & Lichtenberg, P. (2023) · Springer eBooks · doi:10.1007/978-3-031-40371-2_13
Editorial: Case reports in aging psychiatry
Frisardi, V. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.1305521
Wietelmann, D. (2023) · PSYCH up2date · doi:10.1055/a-2057-5115
Maeker, É., & Belmin, J. (2023) · Elsevier eBooks · doi:10.1016/b978-2-294-77815-5.00070-6
Lee, A. T. C., Mok, V., & LAM, L. C. W. (2024) · Springer eBooks · doi:10.1007/978-981-97-1821-4_10
Johnson, K. G., Ford, C. B., Clark, A. G., Greiner, M. A., Lusk, J. B., Perry, C., O’Brien, R., & O'Brien, E. C. (2024) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/08919887241254470
Chapter 61. Treatment During Late Life
Brewster, K., Rutherford, B. R., & Roose, S. P. (2024) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615375523.as61
Delineau, V. M. E. B., Ferreira, A. R., Passos, L., & Fernandes, L. P. N. S. (2024) · Archives of Clinical Neuropsychology · doi:10.1093/arclin/acae097 · Cited by 1
Toward Localizing Psychosis in Pathologically Confirmed Neurodegenerative DiseasePreprint
Breithaupt, A. G., Naasan, G., Shdo, S. M., López, L., Spina, S., Grinberg, L. T., Seeley, W. W., Tempini, M. L. G., Rabinovici, G. D., Kramer, J. H., et al. (2025) · medRxiv · doi:10.1101/2025.02.06.25321537
The digitalization of psychopathology: ‘TV sign’ and ‘Smartphone sign’ as red flags for dementia
Chutia, P., Tripathi, S. M., & Ashwin, J. V. (2025) · Neurocase · doi:10.1080/13554794.2025.2467925
de Oliveira, C., Matias, M. A., Aragón, M. J., Anaya-Montes, M., Osborn, D., & Jacobs, R. (2025) · BJPsych Open · doi:10.1192/bjo.2024.853
Wietelmann, D. (2025) · Geriatrie up2date · doi:10.1055/a-2496-7875
Yang, Y., & Kwak, Y. T. (2025) · American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2025.04.210
Jo, T., & Lim, C. S. (2025) · medRxiv · doi:10.1101/2025.04.24.25326362
Zhang, Y., & Jiang, J. (2025) · Ageing and Neurodegenerative Diseases · doi:10.20517/and.2025.09
NEUROPSYCHIATRIC SYMPTOMS IN ALZHEIMER’S DISEASE - A NARRATIVE REVIEW
Kuźniar, J., Jurczak, P., & Czaja, M. (2025) · International Journal of Innovative Technologies in Social Science · doi:10.31435/ijitss.3(47).2025.3903
Sandeep, S., Sharma, S., & Soman, D. (2025) · SSRN Electronic Journal · doi:10.2139/ssrn.5743962
Real-time hyperspectral imaging and biochemical sensing via explainable optical AI
Wang, Q., Ning, L., Lopez, A. B., Zhao, H., & Fratalocchi, A. (2025) · Optoelectronic Imaging and Multimedia Technology · doi:10.1117/12.3074427
Moriyoshi, H., Akagi, A., Riku, Y., Sone, J., Miyahara, H., Yoshida, M., Katsuno, M., & Iwasaki, Y. (2025) · BMC Neurology · doi:10.1186/s12883-025-04556-z
Matušková, V., Veverová, K., Jester, D. J., Maťoška, V., Ismail, Z., Sheardová, K., Horáková, H., Cerman, J., Laczó, J., Andel, R., et al. (2024) · Figshare · doi:10.6084/m9.figshare.25092515
Self-citationKwan, D., Rashidi‐Ranjbar, N., Marinas, J. E., Namasivayam, A. A., Churchill, N. W., Fornazzari, L., Ismail, Z., Luca, V. D., Schweizer, T. A., Munoz, D. G., et al. (2026) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/08919887261424535
Self-citationWhite Matter Hyperintensities and Neuropsychiatric Symptoms in Neurodegenerative Diseases
Katakami, S., Kanemoto, H., Taomoto, D., Satake, Y., Suehiro, T., Sato, S., Yoshiyama, K., Kashibayashi, T., Takahashi, R., Tagai, K., et al. (2026) · Journal of Clinical Neurology · doi:10.3988/jcn.2025.0408
Burgess, T. B., & Fung, S. S.-P. (2026) · Drugs & Therapy Perspectives · doi:10.1007/s40267-026-01223-2
Johnson, A. S., Houlihan, H. M., Ziaggi, G., Maldonado, A., Smith, A. C., Heuer, L. B., Guzman, D., Okafor, A., Sanchez, T., Palacios, C., et al. (2026) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1002/dad2.70264
Tcheslavski, G. V., Felipe, L., & Ali, K. S. (2026) · Electronics · doi:10.3390/electronics15050931
Ni, S., Guan, L., Jin, Y., Liu, L., Zhu, S., Zhao, W., & Kumar, P. V. (2026) · The EPMA Journal · doi:10.1007/s13167-026-00450-x · Cited by 1
Tariot, P., Chumki, S. R., Wang, D., Such, P., Palma, A. M., Zhang, Z., & Montano, C. B. (2026) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s586701
Beyond Charles Bonnet Syndrome: A Scoping Review of Psychotic Symptoms in Vision Loss
Floros, G. D., Petrou, P., & Mylona, I. (2026) · ALPHA PSYCHIATRY · doi:10.31083/ap47195
Zhang, H., Pang, T., Liao, Y., Lou, X., Zhang, W., Song, P., Wen, H., Xue, Z., Hall, B., & Xu, X. (2026) · medRxiv · doi:10.64898/2026.04.28.26351932
LIU, H., Ju, P., Yang, J., Wang, S., Li, L., Xiao, Y., Zhu, Y., Jiang, J., & Tang, X. (2026) · Frontiers in Public Health · doi:10.3389/fpubh.2026.1797904
Barczak, A. K. (2026) · Healthcare · doi:10.3390/healthcare14101313 · Cited by 1
Alzheimer’s Disease-Associated Cognitive Disabilities
Das, S., & Mishra, P. (2026) · SpringerBriefs in modern perspectives on disability research. · doi:10.1007/978-981-95-7121-5_2
Chen, Y., Lei, C., Wang, Q., Liu, Q., Li, W., Wang, C., Lv, L., & Yue, W. (2026) · Molecular Psychiatry · doi:10.1038/s41380-026-03735-9
Symptomatic treatment for Alzheimer disease: current evidence and future directions
Ballard, C. G., Doherty, P., Ismail, Z., Corbett, A., & Cummings, J. L. (2026) · Nature Reviews Neurology · doi:10.1038/s41582-026-01260-5 · Cited by 3
Self-citationKorowacki, M., Wrzesińska, A., Rusin, I., Mączka, K., Grobecki, D., Kazimierczak, K., Przybylski, M., Kruczek, F., Dyczko, J., & Świrad, B. (2026) · International Journal of Innovative Technologies in Social Science · doi:10.31435/ijitss.3(51).2026.5858
Yano, K., Nagata, T., Nakajima, S., Kito, S., & 品川, 俊. (2026) · Journal of Alzheimer s Disease Reports · doi:10.1177/25424823261494480
Circuit mechanisms of psychotic symptoms across disorders
Braun, U., Wolf, J., Hirjak, D., Schwarz, E., Tost, H., & Meyer‐Lindenberg, A. (2026) · Neuron · doi:10.1016/j.neuron.2026.09.011
Transdiagnostic mechanisms underlying non-affective psychosis: A role for hippocampal networks?
Kaplan, C., Perepezko, K., Pontone, G. M., & Bakker, A. (2026) · American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2026.10.010
Metadata
- Authors
- Ismail, Z., Creese, B., Aarsland, D., Kales, H. C., Lyketsos, C. G., Sweet, R. A., & Ballard, C.
- Affiliations
- University of Calgary (CA)
- University of Exeter (GB)
- King's College London (GB)
- University of California Davis Medical Center (US)
- Johns Hopkins University (US)
- University of Pittsburgh (US)
- Corresponding author
- Ballard, Clive
- ORCID
- Venue
- Nature Reviews Neurology
- Published
- 2022-01-04
- Volume
- 18
- Issue
- 3
- Pages
- 131-144
- ISSN
- 1759-4758 (ISSN-L)
- 1759-4766
- PMC
- PMC9074132
- OpenAlex
- W4205106947
- Cited by
- 189
- References
- 179
- Citations by year
- 2026: 24 · 2025: 47 · 2024: 61 · 2023: 32 · 2022: 25
- FWCI
- 7.10
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Nature Reviews Neurology (publishedVersion, other-oa)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Brunel University Research Archive (BURA) (Brunel University London) (submittedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Research Portal (King's College London) (submittedVersion, other-oa)
- Funders
- Bristol-Myers Squibb
- Eli Lilly and Company
- Pfizer
- AstraZeneca
- GlaxoSmithKline
- Biogen
- Fondation Brain Canada
- Sunovion
- National Football League Players Association
- Eisai
- Astellas Pharma
- Servier
- H. Lundbeck A/S
- Genentech
- National Institute on Aging (P30AG066468, P30AG066507)
- National Institute of Mental Health (R01MH116046)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Keywords
- dementia, drug repurposing, pimavanserin, escitalopram, lithium, cholinesterase inhibitors, vitamin D, non-pharmacological treatment, precision medicine, neuroimaging, neurobiology of psychosis
- MeSH terms
- Aged, Alzheimer Disease, Humans, Psychotic Disorders, Neurodegenerative Diseases, Neurocognitive Disorders, Neuroimaging
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
